GetTopicDetailResponse(id=f980596e42, topicName=DILI, introduction=DILI, content=null, image=null, comments=2, allHits=1572, url=https://h5.medsci.cn/topic?id=5967, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=25889, tagList=[TagDto(tagId=25889, tagName=DILI)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2246279, encodeId=533b22462e986, content=<a href='/topic/show?id=bac8100834b5' target=_blank style='color:#2F92EE;'>#風濕病#</a> <a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=茅益民教授：當風濕病遇到DILI, objectType=article, longId=857865, objectId=3f9e85e865a6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240530/1717054869962_5579292.jpg, objectUrl=/article/show_article.do?id=3f9e85e865a6, replyNumber=0, likeNumber=42, createdTime=2025-01-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=3f9e85e865a6, moduleTitle=茅益民教授：當風濕病遇到DILI, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3f9e85e865a6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243603, encodeId=bfa122436031a, content=<a href='/topic/show?id=802b8e74083' target=_blank style='color:#2F92EE;'>#藥物性肝損傷#</a> <a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=陳成偉教授專訪 | DILI：知易行難，如何填補認知與實踐的鴻溝？, objectType=article, longId=855997, objectId=338b85599eee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732690218078_8538692.jpg, objectUrl=/article/show_article.do?id=338b85599eee, replyNumber=0, likeNumber=53, createdTime=2024-12-19, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=338b85599eee, moduleTitle=陳成偉教授專訪 | DILI：知易行難，如何填補認知與實踐的鴻溝？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=338b85599eee)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1495784, encodeId=75391495e847e, content=<a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=藥物性肝損傷(DILI)診斷：RUCAM量表與結(jié)構(gòu)性專家診斷程序爭鳴, objectType=article, longId=32962, objectId=d813329623c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d813329623c, replyNumber=0, likeNumber=85, createdTime=2014-04-09, rootId=0, userName=mhm292, userId=6da79200098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d813329623c, moduleTitle=藥物性肝損傷(DILI)診斷：RUCAM量表與結(jié)構(gòu)性專家診斷程序爭鳴, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d813329623c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1495783, encodeId=7e8a1495e8358, content=<a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=Lancet Oncol：Pidilizumab聯(lián)合利妥昔單抗治療復發(fā)性濾泡狀淋巴瘤療效顯著, objectType=article, longId=28792, objectId=8dfe28e926c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dfe28e926c, replyNumber=0, likeNumber=93, createdTime=2014-01-03, rootId=0, userName=mhm292, userId=6da79200098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dfe28e926c, moduleTitle=Lancet Oncol：Pidilizumab聯(lián)合利妥昔單抗治療復發(fā)性濾泡狀淋巴瘤療效顯著, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8dfe28e926c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
